Skip to main content
Springer Nature Link
Log in

Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs

  • Published:
Save article
View saved research
Immunologic Research Aims and scope Submit manuscript

Abstract

In animal models, CD8+ T cells are a critical effector mechanism in the protective immunity against malaria. Conventional approaches to the development of many vaccines, including those against malaria, have however proved inadequate. In particular, an alternative approach is needed for the development of vaccines designed to induce a cellular immune response mediated by CD8+ T cells. Advances in the field of molecular immunology during the past decade have provided an insight into the presentation of peptides by MHC class I molecules and their recognition by CD8+ T cells. These studies have provided a conceptual basis for the development of efficacious parasitic and viral vaccines. By a combination of immunochemical and cellular immunologic analyses based on specific peptide binding motifs, a subunit malaria vaccine that includes CD8+ T cell epitopes restricted by the most common class I HLA alleles, including HLA-A2, can now be constructed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. World Health Organization: World malaria situation in 1992. Wkly Epidemiol Rec 1994;69:309–314.

    Google Scholar 

  2. Mulligan HW, Russell P, Mohan BN: Active immunization of fowls againstPlasmodium gallinaceum by injections of killed homologous sporozoites. J Mall Inst India 1941;4: 25–34.

    Google Scholar 

  3. Nussenzweig RS, Vanderberg J, Most H, Orton C: Specificity of protective immunity produced by XirradiatedPlasmodium berghei sporozoites. Nature 1969;22:488–489.

    Article  Google Scholar 

  4. Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS: Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites ofPlasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ 1979;57:165–173.

    PubMed  Google Scholar 

  5. Clyde DF, Most H, McCarthy VC, Vanderberg JP: Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973;266:169–177.

    Article  PubMed  CAS  Google Scholar 

  6. Clyde DF, McCarthy VC, Miller RM, Hornick RB: Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci 1973;266:398–401.

    Article  PubMed  CAS  Google Scholar 

  7. Clyde DF, McCarthy VC, Miller RM, Woodward WE: Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975; 24:397–401.

    PubMed  CAS  Google Scholar 

  8. Rieckmann KH, Carson PE, Becaudoin RL, Cassells JS, Sell KW: Sporozoite induced immunity in man against an Ethiopian strain ofPlasmodium falciparum. Trans R Soc Trop Med Hyg 1974;68:258–259.

    Article  PubMed  CAS  Google Scholar 

  9. Rieckmann KH, Beaudoin RL, Cassells JS, Sell DW: Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ 1979;57:261–265.

    PubMed  Google Scholar 

  10. Herrington DA, Nardin EH, Losonsky G, Bathurst IC, Barr PJ, Hollingdale MR, Edelman R, Levine MM: Satety and immunogenicity of a recombinant sporozoite malaria vanccine againstPlasmodium vivax. Am J Trop Med Hyg 1991;45:695–701.

    PubMed  CAS  Google Scholar 

  11. Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, Hollingdale MR, Ballour WR, Gordon DM: Humoral immune response in volunteers immunized with irradiatedPlasmodium falciparum sporozoites. Am J Trop Med Hyg 1993;49:166–173.

    PubMed  CAS  Google Scholar 

  12. Hoffman SL, Franke ED, Hollingdale MR, Druilhe P: Attacking the infected hepatocyte; in Hoffman SL (ed): Malaria Vaccine Development. Washington, ASM Press, 1996, chap 3, pp 35–76.

    Google Scholar 

  13. Chen DH, Tigelaar RE, Weinbaum FI: Immunity to sporozoite-induced malaria infection in mice. I. The effect of immunization of T and B cell-deficient mice. J Immunol 1977;118:1322–1327.

    PubMed  CAS  Google Scholar 

  14. Spitalny GL, Verhave JP, Meuwissen JH, Nussenzweig RS:Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents. Exp Parasitol 1977;42:73–81.

    Article  PubMed  CAS  Google Scholar 

  15. Egan JE, Weber JL, Ballou WR, Hollingdale MR, Majarian WR, Gordon DM, Maloy WL, Hoffman SL, Wirtz RA, Schneider I, et al: Efficacy of murine malaria sporozoite vaccines: Implications for human vaccine development. Science 1987;236:453–456.

    Article  PubMed  CAS  Google Scholar 

  16. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig RS, Nussenzweig V: Gamma-interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987;330:664–666.

    Article  PubMed  CAS  Google Scholar 

  17. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF: CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 1988;85:573–576.

    Article  PubMed  CAS  Google Scholar 

  18. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F: Cloned cytotoxic T cells recognized an epitope in the circumsporozoite protein and protect against malaria. Nature 1989; 341:323–325.

    Article  PubMed  CAS  Google Scholar 

  19. Rodrigues MM, Cordey A-S, Arreaza G, Corradin G, Romero P, Maryanski JL, Nussenzweig RS, Zavala F: CD8+ cytolytic T cell clones derived against thePlasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 1991; 3:579–585.

    Article  PubMed  CAS  Google Scholar 

  20. Weiss WR, Berzovsky JA, Houghten R, Sedegah M, Hollingdale M, Hoffman SL: A T cell clone directed at the circumsporozoite protein which protects mice against bothP. yoelii andP. berghei. J Immunol 1992; 149:2103–2109.

    PubMed  CAS  Google Scholar 

  21. Khusmith S, Sedegah M, Hoffman SL: Complete protection againstPlasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T cell clone recognizing sporozoite surface protein 2. Infect Immun 1994;62: 2979–2983.

    PubMed  CAS  Google Scholar 

  22. Hoffman SL, Isenbarger D, Long GW, Sedegah M, Szarfman A, Waters L, Hollingdale MR, van der Miede PH, Finbloom DS, Ballou WR: Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 1989;244:1078–1081.

    Article  PubMed  CAS  Google Scholar 

  23. Hoffman SL, Weiss W, Mellouk S, Sedegah M: Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes. Immunol Lett 1990;25: 33–38.

    Article  PubMed  CAS  Google Scholar 

  24. Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF, Berzofsky JA Miller LH, Hoffman SL: Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 1990;171:763–773.

    Article  PubMed  CAS  Google Scholar 

  25. Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA: Genetic control of immunity toPlasmodium yoelii sporozoites. J Immunol 1989;143:4263–4266.

    PubMed  CAS  Google Scholar 

  26. Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA: Genetic restriction of protective immunity toPlasmodium yoelii sporozoites. Bull World Health Organ 1990;68(suppl):104–108.

    PubMed  Google Scholar 

  27. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL: Human cytotoxic T lymphocytes againstPlasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA 1991;88:3300–3304.

    Article  PubMed  CAS  Google Scholar 

  28. Doolan DL, Houghten RA, Good MF: Location of human cytotoxic T cell epitopes within a polymorphic domain of thePlasmodium falciparum circumsporozoite protein. Int Immunol 1991;3:511–516.

    Article  PubMed  CAS  Google Scholar 

  29. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend AR, et al: Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992;360:434–439.

    Article  PubMed  CAS  Google Scholar 

  30. Sedegah M, Sim BKL, Mason C, Nutman T, Malik A, Roberts C, Johnson A, Ochola J, Koech D, Were B, Hoffman SL: Naturally acquired CD8+ cytotoxic T lymphocytes against thePlasmodium falciparum circumsporozoite protein. J Immunol 1992: 149: 966–971.

    PubMed  CAS  Google Scholar 

  31. Doolan DL, Khamboonruang C, Beck H-P, Houghten RA, Good MF: Cytotoxic T lymphocyte (CTL) low-responsiveness to thePlasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: Analysis of human CTL response to most known variants. Int Immunol 1993; 5: 37–46.

    Article  PubMed  CAS  Google Scholar 

  32. De La Cruz VF, Lal AA, McCutchan TF: Sequence variation in putative functional domains of the circumsporozoite protein ofPlasmodium falciparum. J Biol Chem 1987; 262: 11935–11939.

    PubMed  Google Scholar 

  33. Lockyer MJ, Marsh K, Newbold CI: Wild isolates ofPlasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Mol Biochem Parasitol 1989; 37: 275–280.

    Article  PubMed  CAS  Google Scholar 

  34. Doolan DL, Saul AJ, Good MF: Geographically restricted heterogeneity of thePlasmodium falciparum circumsporozoite protein: Relevance for vaccine development. Infect Immun 1992; 60: 675–682.

    PubMed  CAS  Google Scholar 

  35. Good MF, Kumar S, Miller LH: The real difficulties for malaria sporozoite vaccine development: Nonresponsiveness and antigenic variation. Immunol Today 1988; 9: 351–355.

    Article  PubMed  CAS  Google Scholar 

  36. McCutchan TF, Waters AP: Mutations with multiple independent origins in surface antigens mark the targets of biological selective pressure. Immunol Lett 1990; 25: 23–26.

    Article  PubMed  CAS  Google Scholar 

  37. Robson KJ, Hall JR, Davies LC, Crisanti A, Hill AV, Wellems TE: Polymorphism of the TRAP gene ofPlasmodium falciparum. Proc R Soc Lond 1990; 242: 205–216.

    Article  CAS  Google Scholar 

  38. Wizel B, Houghten R, Church P, Tine JA, Lanar DE, Gordon DM, Ballou WR, Sette A, Hoffman SL: HLA-A2 restricted cytotoxic T lymphocyte responses to multiplePlasmodium falciparum sporozoite protein 2 epitopes in sporozoite-immunized volunteers. J Immunol 1995; 155: 766–775.

    PubMed  CAS  Google Scholar 

  39. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JC, Rothbard JA, Bangham CR, Rizza CR, McMichael AJ: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991; 354: 453–459.

    Article  PubMed  CAS  Google Scholar 

  40. Couillin I, Culmann-Penciolelli B, Gomard E, Levy J-P, Guillet J-G, Saragosti S: Impaired CTL recognition due to genetic variations in the main immunogenic region of the HIV-1 nef protein. J Exp Med 1994; 180: 1129–1134.

    Article  PubMed  CAS  Google Scholar 

  41. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel RM: Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 1990; 346: 629–633.

    Article  PubMed  CAS  Google Scholar 

  42. Aebischer T, Moskophidis D, Rohrer UH, Zinkernagel RM, Hengartner H: In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1991; 88: 11047–11051.

    Article  PubMed  CAS  Google Scholar 

  43. de Campos-Lima P-O, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG: T cell responses and virus evolution: Loss of HLA All-restricted CTL epitopes in Epstein-Barr virus isolates from highly All-positive populations by selective mutation at anchor residues. J Exp Med 1994; 179: 1297–1305.

    Article  PubMed  Google Scholar 

  44. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, Giuberti T, Fiaccadori F, Ferrari C: Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994; 180: 933–943.

    Article  PubMed  CAS  Google Scholar 

  45. Hill AVS, Allsopp CEM, Kwiatkowki D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael A, Greenwood BM: Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595–600.

    Article  PubMed  CAS  Google Scholar 

  46. Hill AVS, Yates SNR, Allsopp CEM, Gupta S, Gilbert S, Lalvani A, Aidoo M, Davenport M, Plebanski M: Human leukocyte antigens and natural selection by malaria. Philos Trans R Soc Lond Biol 1994; 346: 379–385.

    Article  PubMed  CAS  Google Scholar 

  47. Alonso PL, Lindsay SW, Armstrong JRM, Contel M, Hill AG, David PH, Fegan G, de Francisco A, Hall AJ, Shenton FC, Cham K, Greenwood BM: The effect of insecticidetreated bed nets on mortality of Gambian chiddren. Lancet 1991; 337: 1499–1502.

    Article  PubMed  CAS  Google Scholar 

  48. Beadle C, McElroy PD, Oster CN, Beier JC, Oloo AJ, Onyango FK, Chumo DK, Bales JD, Sherwood JA, Hoffman SL: Impact of transmission intensity and age onPlasmodium falciparum density and associated fever. Implications for malaria vaccine design. J Infect Dis 1995; 172: 1047–1054.

    PubMed  CAS  Google Scholar 

  49. Briles WE, Stone HA, Cole RK: Mark's disease: Effects of B histocompatibility allolalleles in resistance and susceptible chickens. Science 1977; 195: 193–195.

    Article  PubMed  CAS  Google Scholar 

  50. de Vries RR, Meera-Khan P, Bernini LF, van Loghem E, van Rood JJ: Genetic control of survival in epidemics. J Immunogenet 1979; 6: 271–287.

    Article  PubMed  Google Scholar 

  51. Zinkernagel RM, Doherty PC: MHC-restricted cytotoxic T cells: Studies on the biological role of restriction specificity, function, and responsiveness. Adv Immunol 1979; 27: 51–177.

    Article  PubMed  CAS  Google Scholar 

  52. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, et al: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 1994; 44: 1–18.

    PubMed  CAS  Google Scholar 

  53. Shimokeevitz R, kappler JW, Marrack P, Grey HM: Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med 1983; 158: 303–316.

    Article  Google Scholar 

  54. Babbit B, Allen P, Matsueda G, Haber E, Unanue E: Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 1985; 317: 359–361.

    Article  Google Scholar 

  55. Buus S, Sette A, Colon SM, Jenis DM, Grey HM: Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 1986; 47: 1071–1077.

    Article  PubMed  CAS  Google Scholar 

  56. Buus S, Sette A, Colon SM, GRey HM: Autologous peptides constitutively occupy the antigen binding site on Ia. Science 1988; 242: 1045–1047.

    Article  PubMed  CAS  Google Scholar 

  57. Townsend A, Bodmer H: Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989; 7: 601–624.

    PubMed  CAS  Google Scholar 

  58. Bjorkman P, Saper M, Samraouri B, Bennett S, Strominger J, Wiley D: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506–512.

    Article  PubMed  CAS  Google Scholar 

  59. Bjorkman P, Saper M, Samraouri B, Bennett S, Strominger J, Wiley D: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–518.

    Article  PubMed  CAS  Google Scholar 

  60. Garret TPJ, Bjorkman PJ, Wiley DC: Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989; 342: 364–366.

    Article  Google Scholar 

  61. Madden DR, Gorga JC, Strominger JL, Wiley DC: The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991; 353: 321–325.

    Article  PubMed  CAS  Google Scholar 

  62. Saper M, Bjorkman PJ, Wiley DC: Redefined structure of the human histocompatibility antigen HLA-A2 at 26A resolution. J Mol Biol 1991; 219: 277–319.

    Article  PubMed  CAS  Google Scholar 

  63. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC: Identification of self peptides bound to purified HLA-B27. Nature 1991; 353: 326–329.

    Article  PubMed  CAS  Google Scholar 

  64. Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA: Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 1992; 257: 919–927.

    Article  PubMed  CAS  Google Scholar 

  65. Matsumura M, Fremont DH, Peterson PA, Wilson IA: Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992; 257: 927–934.

    Article  PubMed  CAS  Google Scholar 

  66. Madden D, Gorga J, Strominger J, Wiley D: The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992; 70: 1035–1048.

    Article  PubMed  CAS  Google Scholar 

  67. Madden DR, Garboczi DN, Wiley DC: The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993; 75: 693–708.

    Article  PubMed  CAS  Google Scholar 

  68. Silver ML, Guo HC, Strominger JL, Wiley DC: Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992; 360: 367–369.

    Article  PubMed  CAS  Google Scholar 

  69. Zhang W, Young A, Imarai M, Nathenson SG, Sacchettini J: Crystal structure of the major histocompatibility complex class II H-2Kb molecule containing a single viral peptide: Implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci USA 1992; 89: 8402–8407.

    Google Scholar 

  70. Young ACM, Zhang W, Sacchettini J, Nathenson S: The three-dimensional structure of H-2Db at 2.4 A resolution: Implications for antigendeterminant selection. Cell 1994; 76: 39–50.

    Article  PubMed  CAS  Google Scholar 

  71. Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989; 340: 443–448.

    Article  PubMed  CAS  Google Scholar 

  72. Cerundolo V, Elliot T, Elvin J, Bastin J, Rammensee H-G, Townsend A: The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur J Immunol 1991; 21: 2069–2075.

    Article  PubMed  CAS  Google Scholar 

  73. Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee H-G: Isolation and analysis of naturally processed peptides as recognized by cytotoxic T cell. Nature 1990; 348: 252–254.

    Article  PubMed  CAS  Google Scholar 

  74. Van Bleek GM, Nathenson SG: Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 1990; 348: 213–216.

    Article  PubMed  Google Scholar 

  75. Elliott T, Cerundolo JE, Townsend A: Peptide-induced conformational changes of the class I heavy chain. Nature 1991; 351: 402–406.

    Article  PubMed  CAS  Google Scholar 

  76. Elliott T, Elvin J, Cerundolo V, Allen H, Townsend A: Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains. Eur J Immunol 1992; 22: 2085–2091.

    Article  PubMed  CAS  Google Scholar 

  77. Engelhard VH: Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 1994; 12: 181–207.

    Article  PubMed  CAS  Google Scholar 

  78. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee H-G: Allelespecific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351: 290–296.

    Article  PubMed  CAS  Google Scholar 

  79. Schumacher TNM, De Bruijn MLH, Vernie LN, Kast WMM, Melief CJM, Neefjes JJ, Ploegh HL: Peptide selection by MHC class I molecules. Nature 1991; 350: 703–706.

    Article  PubMed  CAS  Google Scholar 

  80. Germain RN: MHC-associated antigen processing, presentation, and recognition. Adolescence, maturity, and bcyond. Immunologist 1995; 3: 185–191.

    CAS  Google Scholar 

  81. Guo HC, Jardetzky TS, Garrett TP, Lane WS, Strominger JL, Wiley DC: Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 1992; 360: 364–366.

    Article  PubMed  CAS  Google Scholar 

  82. Parham P: Deconstructing the MHC. Nature 1992; 360: 300–301.

    Article  PubMed  CAS  Google Scholar 

  83. Thorpe CJ: Outsize peptides bulge out of the groove. Immunol Today 1993; 14: 51–52.

    Article  PubMed  CAS  Google Scholar 

  84. Matsui M, Hioe CE, Frelinger JA: Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc Natl Acad Sci USA 1993; 90: 674–678.

    Article  PubMed  CAS  Google Scholar 

  85. Madden DR: The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995; 13: 587–622.

    Article  PubMed  CAS  Google Scholar 

  86. Falk K, Rotzschke O: Consensus motifs and peptide ligands of MHC class I molecules. Semin Immunol 1993; 5: 81–94.

    Article  PubMed  CAS  Google Scholar 

  87. Rotzschke O, Falk K: Naturally-occurring peptide antigens derived from the MHC class I-restricted processing pathway. Immunol Today 1991; 12: 447–455.

    Article  PubMed  CAS  Google Scholar 

  88. Rammensee HG, Falk K, Rotzschke O: Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993; 11: 213–244.

    Article  PubMed  CAS  Google Scholar 

  89. Teng JMC, Hogan KT: Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes. Mol Immunol 1994; 31: 459–470.

    Article  PubMed  CAS  Google Scholar 

  90. Brusic V, Rudy G, Harrison LC: MHCPEP: A database of MHC-binding peptides. Nucl Acids Res 1994; 22: 3663–3665.

    Article  PubMed  CAS  Google Scholar 

  91. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: Allele and haplotype frequencies for HLA and complement loci in various ethnic groups; in Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991, Proceedings of the 11th International Histocompatibility Workshop and Conference. Tokyo, Oxford University Press, 1992, vol 1, chap W15.1, pp 1065–1220.

    Google Scholar 

  92. Arnett KL, Parham P: HLA class I nucleotide sequences. Tissue Antigens 1995; 45: 217–245.

    Google Scholar 

  93. Barouch D, Krausa P, Bodmer J, Browning MJ, McMichael A: Identification of a novel HLA-A2 subtype, HLA-A2*0206. Immungogenetics 1995; 41: 388.

    Article  CAS  Google Scholar 

  94. Fernandez-Vina MA, Sun Y, Stastny P: DNA typing for HLA class I alleles. I. Subsets of HLA-A2 and of-A28. Hum Immunol 1992; 33: 163–173.

    Article  PubMed  CAS  Google Scholar 

  95. Krausa P, Brywka M III, Savage D, Hui KM, Bunce M, Ngai JLF, Teo DLT, Ong YW, Barouch D, Allsopp CEM, et al: Genetic polymorphism within HLA-A*02: Significance of alleleic variants within different populations. Tissue Antigens 1995; 45: 223–231.

    Article  PubMed  CAS  Google Scholar 

  96. Browning M, Krausa P: Genetic diversity of HLA-A2: Evolutionary and functional significance. Immunol Today 1996;174:165–170.

    Article  Google Scholar 

  97. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992;255:1261–1266.

    Article  PubMed  CAS  Google Scholar 

  98. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A: Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993;74:929–937.

    Article  PubMed  CAS  Google Scholar 

  99. Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A: Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E2 proteins. J Immunol 1994;152: 3904–3912.

    PubMed  CAS  Google Scholar 

  100. Parker KC, Bednarke MA, Hull LK, Utz U, Cunningham B, Zweerink HJ, Biddison WE, Colligan JE: Sequence motifs important for peptide binding to the human MHC class I molecule. J Immunol 1992;149:3580–3587.

    PubMed  CAS  Google Scholar 

  101. Jameson SC, Bevan MJ: Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur J Immunol 1992;22:2663–2667.

    Article  PubMed  CAS  Google Scholar 

  102. Barouch D, Friede T, Stevanovic S, Tussey L, Smith K, Rowland-Jones S, Braud V, McMichael A, Rammensee H-G: HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med 1995;182:1847–1856.

    Article  PubMed  CAS  Google Scholar 

  103. Sudo T, Kamikawaji N, Kimura A, Date Y, Savoie CJ, Nakashima H, Furuichi E, Kuhara S, Sasazuki T: Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol 1995;155: 4749–4756.

    PubMed  CAS  Google Scholar 

  104. del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A: Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995; 154:685–693.

    PubMed  Google Scholar 

  105. Tanigaki N, Fruci D, Chersi A, Falasca G, Tosi R, Butler RH: HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol 1994;39:155–162.

    Article  PubMed  CAS  Google Scholar 

  106. Yoshida N, Nussenzweig RS, Potocnjak P, Nussenzweig V, Aikawa M: Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 1980;207:71–73.

    Article  PubMed  CAS  Google Scholar 

  107. Dame JB, Williams JL, McCutchan TF, Weber JL, Wirtz RA, Hockmeyer WT, Maloy WL, Haynes JD, Schneider I, Roberts D, et al: Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasitePlasmodium falciparum. Science 1984; 225:593–599.

    Article  PubMed  CAS  Google Scholar 

  108. Robson KJ, Hall JR, Jennings MW, Harris TJ, Marsh K, Newbold CI, Tate VE, Weatherall DJ: A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 1988; 335:79–82.

    Article  PubMed  CAS  Google Scholar 

  109. Hedstrom RC, Campbell JR, Leef ML, Charoenvit Y, Carter M, Sedegah M, Beaudoin RL, Hoffman SL: A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull World Health Organ 1990;68(suppl): 152–157.

    PubMed  Google Scholar 

  110. Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, Gordon DM, Nussler AK, Aikawa M, Hoffman SL: Characterization ofPlasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA 1992;89: 9176–9180.

    Article  PubMed  CAS  Google Scholar 

  111. Guérin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau Puijalon O, Langsley G: A liver-stage-specific antigen ofPlasmodium falciparum characterized by gene cloning. Nature 1987;329:164–167.

    Article  PubMed  Google Scholar 

  112. Zhu J, Hollingdale M: Structure ofPlasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol 1991;48:223–226.

    Article  PubMed  CAS  Google Scholar 

  113. Fidock DA, Bottius E, Brahimi K, Moelans II, Aikawa M, Konings RN, Certa U, Olafsson P, Kaidoh T, Asavanich A, Guérin-Marchand C, Druilhe P: Cloning and characterization of a novelPlasmodium falciparum sporozoite surface antigen, STARP. Mol Biochem Parasitol 1994;64:219–232.

    Article  PubMed  CAS  Google Scholar 

  114. Hope IA, Mackay M, Hyde JE, Goman M, Scaife J: The gene for an exported antigen of the malaria parasitePlasmodium falciparum cloned and expressed inEscherichia coli. Nucleic Acids Res 1985; 13:369–379.

    Article  PubMed  CAS  Google Scholar 

  115. Coppel RL, Favaloro JM, Crewther PE, Burkot TR, Bianco AE, Stahl HD, Kemp DJ, Anders RF, Brown GV: A blood stage antigen ofPlasmodium falciparum shares determinants with the sporozoite coat protein. Proc Natl Acad Sci USA 1985;82:5121–5125.

    Article  PubMed  CAS  Google Scholar 

  116. Doolan DL, Hedstrom RC, Rogers WO, Charoenvit Y, Rogers M, de la Vega P, Hoffman SL: Characterization of the protective hepatocyte erythrocyte protein 17 kDa gene ofPlasmodium yoelii: Homolog ofP. falciparum exported protein-1. J Biol Chem 1996;271: 17861–17868.

    Article  PubMed  CAS  Google Scholar 

  117. Rotzschke O, Falk K, Stevanovic S, Jung G, Rammensee H-G: Peptide motifs of closely related class I molecules encompass substantial differences. Eur J Immunol 1992; 22:2453–2456.

    Article  PubMed  CAS  Google Scholar 

  118. Salter RD, Creswell P: Impaired assembly and transport of HLA-A and-B antigens in a mutant T x B cell hybrid. EMBO J 1986;5:943–949.

    PubMed  CAS  Google Scholar 

  119. Reddehase M, Rothbard JB, Koszinowski UH: A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 1989;337:651–653.

    Article  PubMed  CAS  Google Scholar 

  120. Chen Y, Sidney J, Southwood S, Cox AL, Sakaguchi K, Henderson RA, Appella E, Hunt DF, Sette A, Engelhard VH: Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J Immunol 1994; 152:2874–2881.

    PubMed  CAS  Google Scholar 

  121. Widmann C, Maryanski JL, Romero P, Corradin G: Differential stability of antigenic MHC class I-restricted synthetic peptides. J Immunol 1991;147:3745–3751.

    PubMed  CAS  Google Scholar 

  122. Falo LD, Colarusso LJ, Benacerraf B, Rock KL: Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules. Proc Natl Acad Sci USA 1992;89:8347–8350.

    Article  PubMed  CAS  Google Scholar 

  123. Kozlowski S, Corr M, Takeshita T, Boyd LF, Pendleton D, Germain RN, Berzofsky JA, Margulies DH: Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med 1992; 175:1417–1422.

    Article  PubMed  CAS  Google Scholar 

  124. Sherman LA, Burke TA, Biggs JA: Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J Exp Med 1992;175:1221–1226.

    Article  PubMed  CAS  Google Scholar 

  125. Aidoo M, Lalvani A, Allsopp CEM, Plebanski M, Meisner SJ, Krausa P, Browning M, Morris-Jones S, McAdam S, Gotch F, et al: Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995;345: 1003–1007.

    Article  PubMed  CAS  Google Scholar 

  126. von Heijne G: Signal sequences. The limit of variation. J Mol Biol 1985;184:99–105.

    Article  Google Scholar 

  127. Wizel B, Rogers WO, Houghten RA, Lanar DE, Tine JA, Hoffman SL: Induction of murine cytotoxic T lymphocytes againstPlasmodium falciparum sporozoite surface protein 2. Eur J Immunol 1994;24: 1487–1495.

    Article  PubMed  CAS  Google Scholar 

  128. Buchmeier MJ, Zinkernagel RM: Immunodominant T cell epitope from signal sequence. Science 1992;257:1142.

    Article  PubMed  CAS  Google Scholar 

  129. Wei ML, Creswell P: HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 1992;356:443–446.

    Article  PubMed  CAS  Google Scholar 

  130. Shira M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten RA, Pendelton CD, Feinstoen SM, Berzofsky JA: An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994;68:3334–3342.

    Google Scholar 

  131. Blum-Tirouvanziam U, Servis C, Habluetzel A, Valmori D, Men Y, Esposito F, Del Nero L, Holmes N, Fasel N, Corradin G: Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein ofPlasmodium falciparum. J Immunol 1995;154:3922–3931.

    PubMed  CAS  Google Scholar 

  132. Allsopp CEM, Hardin RM, Taylor C, Bunce M, Kwiatkowski D, Anstey N, Brewster D, McMichael AJ, Greenwood BM, Hill AVS: Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am J Hum Genet 1992; 50:411–421.

    PubMed  CAS  Google Scholar 

  133. Lalvani A, Allsopp CEM, Plebanski M, Whittle HC, Hill AVS: An HLA-based approach to the design of a CTL-inducing vaccine againstPlasmodium falciparum. Res Immunol 1994;145:461–468.

    Article  PubMed  CAS  Google Scholar 

  134. Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL: Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of thePlasmodium falciparum sporozoite surface protein 2. J Exp Med 1995;182:1435–1445.

    Article  PubMed  CAS  Google Scholar 

  135. Lieberman J, Fabry JA, Kuo MC, Earl P, Moss B, Skolnik PR: Cytotoxic T lymphocytes from HIV-I seropositive individuals recognize immunodominant epitopes in gp160 and reverse transcriptase. J Immunol 1992;148:2738–2747.

    PubMed  CAS  Google Scholar 

  136. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, et al: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59–64.

    Article  PubMed  Google Scholar 

  137. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, Sette A, Chisari FV: The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047–1058.

    Article  PubMed  CAS  Google Scholar 

  138. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching W-M, Grakoui A, Rice CM, Kurokohchi K, et al: Patients with chronic hepatitic C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995;69: 2462–2470.

    PubMed  CAS  Google Scholar 

  139. Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG: T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv 1992;1992:53–80.

    Google Scholar 

  140. Rosenberg R, Wirtz RA, Schneider I, Burge R: An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans R Soc Trop Med Hyg 1990; 84:209–212.

    Article  PubMed  CAS  Google Scholar 

  141. Baird JK: Host age as a determinant of naturally acquired immunity toPlasmodium falciparum. Parasitol Today 1996;11:105–111.

    Article  Google Scholar 

  142. Doolan DL, Houghten RA, Good MF: Assessment of human cytotoxic T cell activity using synthetic peptides: Potential for field application. Peptide Res 1991;4:125–131.

    CAS  Google Scholar 

  143. Rodrigues M, Nussenzweig RS, Romero P, Zavala F: The in vivo cytotoxic activity of CD8+ T cell clones correlated with their levels of expression of adhesion molecules. J Exp Med 1992;175:895–905.

    Article  PubMed  CAS  Google Scholar 

  144. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FC: CTL access to tissue antigen is restricted in vivo. J Immunol 1994;153:482–488.

    PubMed  CAS  Google Scholar 

  145. Adams DH, Hubscher SG, Shaw J, Rothlein R: Intercellular adhesion molecules on liver allografts during rejection. Lancet 1989;ii: 1122–1124.

    Article  Google Scholar 

  146. Volpes R, van der Oord JJ, Desmet VJ: Hepatic expression of intracellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology 1990;12:148–154.

    Article  PubMed  CAS  Google Scholar 

  147. Volpes R, van der Oord JJ, Desmet VJ: Adhesive molecules in liver disease: Immunochemical distribution of thrombospondin receptors in chronic HBV infection. J Hepatol 1990;10:228–241.

    Article  Google Scholar 

  148. Paroli M, Franco A, De Petrillo G, Alfani E, Perrone A, Barnaba V: Human hepatoma cells expressing MHC antigens display accessory cell function: Dependence on LFA-1/ICAM-1 interaction. Immunology 1994;82:215–221.

    PubMed  CAS  Google Scholar 

  149. Sakamoto T, Mabuchi A, Kuriya S, Aida T, Asano T, Shoji T, Yokomuro K: Production of granulocyte-macrophage colony-stimulating factor by adult murine parenchymal liver cells (hepatocytes). Reg Immunol 1991;3:260–267.

    CAS  Google Scholar 

  150. Thornton AJ, Ham J, Kunkel HJ: Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1991;14:1112–1122.

    PubMed  CAS  Google Scholar 

  151. Shedlofsky SI, McClain CJ: in Kimball S (ed): Cytokines and Inflammation. Boca Raton, CRC Press, 1986, pp 235–273.

    Google Scholar 

  152. Jiang X, Gregory SH, Wing EJ: Hepatocytes can serve as accessory cells in the response of immune T lymphocytes to heat-killedListeria monocytogenes. Infect Immun 1995;63:926–933.

    PubMed  CAS  Google Scholar 

  153. Demotz S, Grey HM, Sette A: The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 1990;249: 1028–1030.

    Article  PubMed  CAS  Google Scholar 

  154. Christnick ER, Luscher MA, Barber BH, Williams DB: Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 1991;352:67–70.

    Article  Google Scholar 

  155. Wallny HJ, Deres K, Faath S, Jung G, Van Pel A, Boon T, Rammensee H-G: Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int Immunol 1992;4:1085–1090.

    Article  PubMed  CAS  Google Scholar 

  156. Harding CV, Unanue ER: Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 1990;346:574–576.

    Article  PubMed  CAS  Google Scholar 

  157. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A: Serial Triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;3775:148–151.

    Article  Google Scholar 

  158. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJM, Oseroff C, Yuan L, Ruppert J, et al: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994;153:5586–5592.

    PubMed  CAS  Google Scholar 

  159. Niedermann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschutzky H, Jung G, Maier B, Eichmann K: Contribution of proteosome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995;2:289–299.

    Article  PubMed  CAS  Google Scholar 

  160. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11:729–766.

    Article  PubMed  CAS  Google Scholar 

  161. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Koppe B, Sigmund K, Bangham CRM, McMichael AJ: Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995;375:606–611.

    Article  PubMed  CAS  Google Scholar 

  162. Barber LD, Parham P: The essence of epitopes. J Exp Med 1994;180: 1191–1194.

    Article  PubMed  CAS  Google Scholar 

  163. Aggarwal A, Kumar S, Jaffe R, Hone D, Gross M, Sadoff J: OralSalmonella: Malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J Exp Med 1991;172:1083–1090.

    Article  Google Scholar 

  164. Satchidanandam V, Zavala F, Moss B: Studies using recombinant vaccinia virus expressing the circumsporozoite protein ofP. berghei. Mol Biochem Parasitol 1991;48:89–100.

    Article  PubMed  CAS  Google Scholar 

  165. Sedegah M, Beaudoin RL, de la Vega P, Leef MF, Ozcel MA, Jones E, Charoenvit Y, Yuan LF, Gross M, Majarian WR, Robey FA, Weiss W, Hoffman SL: Use of a vaccinia construct expressing the circumsporozoite protein in the analysis of protective immunity toPlasmodium yoelii; in Lasky L (ed): Technological Advances in Vaccine Development. New York, Liss, 1988, pp 295–309.

    Google Scholar 

  166. Sedegah M, Beaudoin RL, Majarian WR, Cochran MD, Chiang CH, Sadoff J, Aggarwal A, Charoenvit Y, Hoffman SL: Evaluation of vaccines designed to induce protective cellular immunity against thePlasmodium yoelii circumsporozoite protein: Vaccinia, pseudorabies, andSalmonella transformed with circumsporozoite gene. Bull World Health Organ 1990;68(suppl):109–114.

    PubMed  Google Scholar 

  167. Flynn JL, Weiss WR, Norris KA, Seifert HS, Kumar S, So M: Generation of a cytotoxic T-lymphocyte response using aSalmonella antigen-delivery system. Mol Microbiol 1990;4:2111–2118.

    Article  PubMed  CAS  Google Scholar 

  168. Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghten RA, Beaudoin RL, Smith D, Hoffman SL: Recombinant pseudorabies virus carrying a plasmodium gene: Herpesvirus as a new live viral vector for inducing T- and B-cell immunity. Vaccine 1992;10:578–584.

    Article  PubMed  CAS  Google Scholar 

  169. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL: Circumventing genetic restriction of protection against malaria with multi-gene DNA immunization: CD8+ T cell, interferon-γ, and nitric oxide dependent immunity. J Exp Med 1996;183:1739–1746.

    Article  PubMed  CAS  Google Scholar 

  170. Seguin MC, Klotz FW, Schneider I, Weir JP, Goodbary M, Slayter M, Raney JJ, Aniagolu JU, Green SJ: Induction of nitric oxide synthase protects against malaria in mice exposed to irradiatedPlasmodium berghei infected mosquitoes: Involvement of interferon gamma and CD8+ T cells. J Exp Med 1994;180:353–358.

    Article  PubMed  CAS  Google Scholar 

  171. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development. J Exp Med 1992;176:169–176.

    Article  PubMed  CAS  Google Scholar 

  172. McMichael AJ: Cytotoxic T lymphocytes specific for influenza virus. Curr Top Microbiol Immunol 1994;189:75–91.

    PubMed  CAS  Google Scholar 

  173. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, Chisari FV: HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 1993;177:751–762.

    Article  PubMed  CAS  Google Scholar 

  174. Nixon D, Broliden K, Ogg G, Broliden P: Cellular and humoral antigenic epitopes in HIV and SIV. Immunology 1992;76:515–534.

    PubMed  CAS  Google Scholar 

  175. Johnson RP, Trocha A, Yang L, Mazzara GP, Panicali DL, Buchanan TM, Walker BD: HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gas-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J Immunol 1991;147:1512–1521.

    PubMed  CAS  Google Scholar 

  176. Hadida F, Parrot A, Kieny MP, Sadat-Sowti B, Mayaud C, Debré P, Autran B: Carboxyl-terminal and central regions of human immunodeficiency virus-1 nef recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest 1992;89:53–60.

    Article  PubMed  CAS  Google Scholar 

  177. Clerici M, Lucey DR, Zajac RA, Boswell RN, Gebel HM, Takahashi H, Berzofsky JA, Shearer GM: Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol 1991;146: 2214–2219.

    PubMed  CAS  Google Scholar 

  178. Dadaglio GA, Leroux DP, Langlade DP, Bahraoui EM, Traincard F, Fisher R, Plata F: Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J Immunol 1991; 147:2302–2309.

    PubMed  CAS  Google Scholar 

  179. Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV: HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993; 150:4659–4671.

    PubMed  CAS  Google Scholar 

  180. Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CRM: Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 1994;68:2860–2868.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Microbiology and Immunology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Md., USA

    Benjamin Wizel

  2. Malaria Program, Naval Medical Research Institute, 12300 Washington Avenue, 20852, Rockville, MD, (USA)

    Denise L. Doolan, Benjamin Wizel & Stephen L. Hoffman

Authors
  1. Denise L. Doolan
    View author publications

    Search author on:PubMed Google Scholar

  2. Benjamin Wizel
    View author publications

    Search author on:PubMed Google Scholar

  3. Stephen L. Hoffman
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doolan, D.L., Wizel, B. & Hoffman, S.L. Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs. Immunol Res 15, 280–305 (1996). https://doi.org/10.1007/BF02935313

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1007/BF02935313

Key Words